Where has the time gone

I’ve got to say, the past week has been nice, but its disappeared in the blink of an eye.  It seems like just yesterday I was ‘welcoming’ Monday at the office, and now, after a long weekend, I’m looking down the barrel of another horrible Monday.  But, all is not lost, because I’ve got a great run planned for the morning, and I’m not going in until lunch, because, why not.  It really gets down to utilizing my spendable days when available for leave accrued at work, so when I decide to make a move, my leadership traditionally approves of my actions because they are so rare 

And so, today we are going to discuss rarity; our Chapter 5 topic in relation to IFRX.   In the world of business, Rarity does not equate to valuable.  Just because you are unique, does not make you special.  (**insert insensitive joke here**).  But in all honesty, our company has spent the past several years attempting to cure a common ailment (Hidradenitis Suppurativa) that no one has yet discover a cure for.  Companies such as IFRX are numerous, as the Biotech industry is a long history of build and bust type stories.  A few doctors and researchers go off on their own, find some investors, and attempt to solve a few illnesses and make millions in the process.  So when IFRX was on the verge of solving this condition, and being the only known cure, everyone was ready to pounce on the investment (cause its rare…hello!!)  But it was not meant to be, IFRX was not the rare exception to the industry with a proven winner, and instead, they are now just a piece of the mechanism, with a highly deflated stock price (highly un-rare like all the other bio companies)